Skip to main content
. 2014 Nov 13;13(2):184–196. doi: 10.2450/2014.0174.14

Table II.

Prevalence of parvovirus B19 reported in blood product recipients with bleeding disorders.

Prevalence of B19V antibody (%) Subjects of study Study author and year of publication

  1. Haemophilia A: 42.1

  2. Haemophilia B: 35.5

  3. vWD: 37.9

  4. Rare factor deficiencies: 55.8

 Patients with bleeding disorders Soucie JM, 201366
Haemophilia: 64.2 Patients with haemophilia, malignant disease, immunodeficiency diseases, common gynaecological ailments, pregnant women and children with malignant diseases. Reinheimer C, 2010118
91.8 Patients with haemophilia Langara H, 2005119
21 to 48.5 Patients with haemophilia A Soucie JM, 2004120

  1. Haemophilia A: 79.2

  2. Haemophilia B: 83.3

  3. Controls: 34.6

IgM was found in 2 patients with haemophilia.
No B19V DNA was found.		 Patients with haemophilia Brojer E, 1999121
76.7 Patients with bleeding disorders Canales MA, 1998122

  1. Haemophilia A: 93

  2. Haemophilia B: 97

  3. vWD: 80

Total 93		 Patients with bleeding disorders Mauser-Bunschoten EP, 1998123
IgG: 84
IgM: 0		 Patients with bleeding disorders Aguilar Franco C 1997124
81.6 Patients with haemophilia Ragni MV, 1996125

  1. Haemophiliacs: 31

  2. Controls: 5

 Patients with haemophilic arthritis Zakrzewska K, 2001126

  1. Haemophiliacs:

    55.5 Heated products

    93.3 Unheated products

  2. Healthy donors: 29.3

 Patients with haemophilia and healthy donors Bartolomei Corsi O, 1988127

B19V: parvovirus B19; vWD: von Willebrand disease; IgG: immunoglobin G; IgM: immunoglobin M.